EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Toll-like receptor-3 contributes to the development of aortic valve stenosis

Sven Thomas Niepmann, Nicola Willemsen, Ann Sophie Boucher, Marta Stei, Philip Goody, Andreas Zietzer, Marko Bulic, Hannah Billig, Alexandru Odainic, Christina Katharina Weisheit, Christine Quast, Matti Adam und 6 weitere

Basic Research in Cardiology · 01.02.2023 · 118 (1)

DOI: 10.1007/s00395-023-00980-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic Research in Cardiology, online erschienen am 01.02.2023. Verfasst von Sven Thomas Niepmann und 17 weiteren Autor:innen. Beteiligte Einrichtung: Heart Center Bonn, Clinic for Internal Medicine II, University Hospital Bonn, Bonn, Germany. sven.niepmann@ukbonn.de. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Calcinosis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Else Kröner-Fresenius-Stiftung, Rheinische Friedrich-Wilhelms-Universität Bonn.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aortic valve stenosis (AS) development is driven by distinct molecular and cellular mechanisms which include inflammatory pathways. Toll-like-receptor-3 (TLR3) is a lysosomal pattern-recognition receptor that binds double-stranded RNA and promotes pro-inflammatory cellular responses. In recent years, TLR3 has emerged as a major regulator of vascular inflammation. The exact role of TLR3 in the development of AS has not been investigated. Isolated human valvular interstitial cells (VICs) were stimulated with the TLR3-agonist polyIC and the resulting pro-inflammatory and pro-osteogenic response measured. Severe AS was induced in wildtype- and TLR3 −/− mice via mechanical injury of the aortic valve with a coronary springwire. TLR3 activation was achieved by polyIC injection every 24 h after wire injury, while TLR3 inhibition was realized using Compound 4a (C4a) every 48 h after surgery. Endothelial mesenchymal transition (EndoMT) of human valvular endothelial cells (VECs) was assessed after polyIC stimulation. Stimulation of human VICs with polyIC promoted a strong inflammatory and pro-osteogenic reaction. Similarly, injection of polyIC marginally increased AS development in mice after wire injury. AS induction was significantly decreased in TLR3 −/− mice, confirming the role of endogenous TLR3 ligands in AS pathology. Pharmacological inhibition of TLR3 with C4a not only prevented the upregulation of inflammatory cytokines and osteogenic markers in VICs, and EndoMT in VECs, but also significantly abolished the development of AS in vivo. Endogenous TLR3 activation significantly contributes to AS development in mice. Pharmacological inhibition of TLR3 with C4a prevented AS formation. Therefore, targeting TLR3 may be a viable treatment option.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Valve StenosisCalcinosisHumansMiceAnimalsAortic ValveEndothelial CellsToll-Like Receptor 3Cells, Cultured

Stichwörter der Autor:innen

Aortic valve stenosisInnate immune systemToll-like receptorsValvular endothelial cellsValvular interstitial cells

Substanzen

Toll-Like Receptor 3

Autor:innen und Institutionen

  • Heart Center Bonn, Clinic for Internal Medicine II, University Hospital Bonn, Bonn, Germany. sven.niepmann@ukbonn.de.
  • Heart Center Bonn, Clinic for Internal Medicine II, University Hospital Bonn, Bonn, Germany.
  • Institute of Innate Immunity, University Hospital Bonn, Bonn, Germany.
  • Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.
  • Department of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.
  • Cardiovascular Research Laboratory, Division of Cardiology, Pulmonary Diseases and Vascular Medicine, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.

Förderung

  • Deutsche Forschungsgemeinschaft
  • Else Kröner-Fresenius-Stiftung
  • Rheinische Friedrich-Wilhelms-Universität Bonn

Zitieren

APA

Niepmann, S. T., Willemsen, N., Boucher, A. S., Stei, M., Goody, P., Zietzer, A., Bulic, M., Billig, H., Odainic, A., Weisheit, C. K., Quast, C., Adam, M., Schmidt, S. V., Bakhtiary, F., Jansen, F., Nickenig, G., Latz, E., & Zimmer, S. (2023). Toll-like receptor-3 contributes to the development of aortic valve stenosis. Basic Research in Cardiology, 118(1). https://doi.org/10.1007/s00395-023-00980-9

Vancouver

Niepmann ST, Willemsen N, Boucher AS, Stei M, Goody P, Zietzer A, et al. Toll-like receptor-3 contributes to the development of aortic valve stenosis. Basic Research in Cardiology. 2023;118(1). doi:10.1007/s00395-023-00980-9

BibTeX
@article{Niepmann2023,
  author = {Niepmann, Sven Thomas and Willemsen, Nicola and Boucher, Ann Sophie and Stei, Marta and Goody, Philip and Zietzer, Andreas and Bulic, Marko and Billig, Hannah and Odainic, Alexandru and Weisheit, Christina Katharina and Quast, Christine and Adam, Matti and Schmidt, Susanne V and Bakhtiary, Farhad and Jansen, Felix and Nickenig, Georg and Latz, Eike and Zimmer, Sebastian},
  title = {Toll-like receptor-3 contributes to the development of aortic valve stenosis},
  journal = {Basic Research in Cardiology},
  year = {2023},
  volume = {118},
  number = {1},
  doi = {10.1007/s00395-023-00980-9}
}
Kostenlos starten →